https://scholars.lib.ntu.edu.tw/handle/123456789/434306
標題: | Increased trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma | 作者: | HUANG-CHUN LIEN YUNG-MING JENG Jhuang Y.-L. RAY-HWANG YUAN |
公開日期: | 2018 | 出版社: | Public Library of Science | 卷: | 13 | 期: | 10 | 來源出版物: | PLoS ONE | 摘要: | Introduction: Trimethylation of histone H3K36 (H3K36me3), an epigenetic marker of transcription-associated histone modification and stem cell regulation, is expressed in a variety of human cancers. This study elucidated the prognostic significance of H3K36me3 in patients with resectable hepatocellular carcinoma (HCC). Methods: Expression of H3K36me3 was retrospectively evaluated through immunohistochemistry in 152 surgically resected primary HCCs. Results: In nontumorous liver parenchyma, H3K36Me3 was detected in bile ducts but not in hepatocytes. H3K36me3 was positive in 104 (68.4%) of the HCCs. Positivity for H3K36me3 was associated with high level of serum α-fetoprotein (>200 ng/mL, P = 0.0148), high tumor grade (P = 0.0017), and high tumor stage (P = 0.0008). Patients with H3K36me3-positive tumors were more likely to have lower 5-year disease-free survival and 5-year overall survival than those with H3K36me3-negative tumors (P = 0.0484 and P = 0.0213, respectively). Multivariate analysis showed that H3K36me3 positivity was an independent predictor of high tumor grade (P = 0.0475) and high tumor stage (P = 0.0114) and thus contributed to poor prognosis. Furthermore, H3K36me3 positivity was significantly correlated with the expression of biliary markers cytokeratin 19 (CK19) and hepatocyte nuclear factor 1β (HNF1β) (P < 0.0001 and P = 0.0005, respectively). Combinatorial analysis revealed that CK19 and HNF1β expression individually exerted additive prognostic adverse effects on HCCs with H3K36me3 positivity. Conclusions: Our study indicates that H3K36me3 positivity is associated with the expression of biliary markers and is a crucial predictor of poor prognosis in resectable HCC. ? 2018 Lien et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055445830&doi=10.1371%2fjournal.pone.0206261&partnerID=40&md5=8fa570cb6c1fc9fefb6e4cc36a0429eb https://scholars.lib.ntu.edu.tw/handle/123456789/434306 |
ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0206261 | SDG/關鍵字: | alpha fetoprotein; cytokeratin 19; hepatocyte nuclear factor 1beta; histone H3; histone H3K36; unclassified drug; beta catenin; cytokeratin 19; hepatocyte nuclear factor 1beta; histone; adult; Article; cancer grading; cancer growth; cancer prognosis; cancer staging; cancer survival; clinical evaluation; cohort analysis; controlled study; correlational study; disease free survival; female; histone methylation; human; human cell; human tissue; immunohistochemistry; liver cell; liver cell carcinoma; liver parenchyma; major clinical study; male; middle aged; overall survival; protein blood level; protein expression; retrospective study; Taiwan; tumor recurrence; tumor volume; adolescent; aged; bile duct; epithelium cell; genetics; Kaplan Meier method; liver cell carcinoma; liver tumor; metabolism; methylation; mutation; pathology; prognosis; tumor suppressor gene; very elderly; Adolescent; Adult; Aged; Aged, 80 and over; beta Catenin; Bile Ducts; Carcinoma, Hepatocellular; Epithelial Cells; Female; Genes, p53; Hepatocyte Nuclear Factor 1-beta; Histones; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Keratin-19; Liver Neoplasms; Male; Methylation; Middle Aged; Mutation; Prognosis; Retrospective Studies |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。